Diagnostic and Biotech

North America Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), Antisense RNA and Others), Application (Genetic Engineering, Cell Line Engineering and Others) End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes), and Country

  • THE3207018
  • 155 Pages
  • April 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The North America genome editing market is expected to reach US$ 4,148.1 Mn in 2025 from US$ 1,234.5 Mn in 2017. The market is estimated to grow with a CAGR of 17.2% from 2018-2025.

The growth of the genome editing market is primarily attributed to the rise in the production of genetically modified crops and rising prevalence of the genetic diseases. However, the stringent regulatory framework and limitations in genome editing are likely to pose a negative impact on the market growth. On the other hand, emerging markets for precision and regenerative medicines is likely to have a positive impact on the growth of the North America genome editing market in the coming years.

The genome editing has proved itself to be the most promising way of feeding the fast growing population across the world. The changes in the climatic conditions due to the global warming and others conditions such as droughts floods are witnessed more across the world. Therefore, the feeding the rising population is question among the people across the world. Due to the genome editing the concerns are being reduced to a great level, the two types of the genetically modified crops are widely grown. Firstly, these crops are altered in a ways that they are not affected by the herbicide glyphosate. Secondly, crops are produced to protect themselves from the insecticides. The advantages of the genetically modified crops includes diseases resistance, improvement of the photosynthesis, improvement of the nutrition, and more. The genetic modification helps to enhance the productivity without hampering the health of the crops. In addition, for the genetically modified crops the limited resources are required and it require less or no pesticides for its growth. The time required for the growth of the genetically modified crops is less, therefore these are highly preferred crops in the western world. The demand for the genetically modified crops is rising in the eastern region due to the benefits offered by these crops.

According to the International Service For The Acquisition Of Agri-Biotech Applications (ISAAA), 2017 statistics, 19 developing countries have planted 53% which is approximately to 100.6 million hectares of the global biotech hectares, whereas the 5 industrial countries have took the 47% which is near about 89.2 million hectares share. The trend of growing genetically modified crop is expected to grow in the coming future.

In 2017, the CRISPR segment segment held a largest market share of 53.6% of the genome editing market, by technology. This segment is also expected to dominate the market in 2025 owing to the simple, fast and accurate property of the CRISPR. Moreover, the TALENs segment is anticipated to witness the significant growth rate of 17.1% during the forecast period, 2018 to 2025 owing to the properties provided by the TALENs the market for it is expected to rise in the coming near future.

North America genome editing market, based on application was segmented into genetic engineering, cell line engineering and others. The cell line engineering segment is anticipated to grow at a CAGR of 18.0% during the forecast period. Moreover, the genetic engineering segment is expected to grow at the significant rate during the coming years owing to its sub segments such as animal genetic engineering and plant genetic engineering that are being carried out extensively. In 2017, the biotechnology & pharmaceutical companies segment held a largest market share of 61.2% of the genome editing market, by end user. This segment is also expected to dominate the market in 2025 owing to the advantages of the CRISPR, the companies have enhanced their research and development for the drug discoveries that can treat various diseases. Hence, the market is likely to propel in the coming years.

Some of the major primary and secondary sources for genome editing included in the report are, Contract Research Organizations (CRO), United States Department of Agriculture (USDA), National Institutes of Health (NIH), Abu Dhabi Fund for Development (ADFD), Ministry of Science and Technology (MST), International Service For The Acquisition Of Agri-Biotech Applications (ISAAA), Food and Drug Administration (FDA), Department of Biotechnology (DBT) and others.

TABLE OF CONTENTS

PART 1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. NORTH AMERICA GENOME EDITING TESTING MARKET - KEY TAKEAWAYS

PART 3. NORTH AMERICA GENOME EDITING MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 North America Genome Editing Market - By Technology

3.2.2 North America Genome Editing Market - By Application

3.2.3 North America Genome Editing Market - By End User

3.2.4 North America Genome Editing Market - By Country

3.3 PEST ANALYSIS

PART 4. NORTH AMERICA GENOME EDITING MARKET- KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Rise in the Production of Genetically Modified Crops

4.1.2 Rising Prevalence of The Genetic Diseases

4.2 KEY MARKET RESTRAINTS

4.2.1 Stringent Regulatory Framework

4.2.2 Limitations in Genome Editing

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Emerging Markets For Precision and Regenerative Medicines

4.4 FUTURE TRENDS

4.4.1 Rising Demand for CRISPR Cas9 Technology

4.5 IMPACT ANALYSIS

PART 5. GENOME EDITING MARKET - NORTH AMERICA ANALYSIS

5.1 NORTH AMERICA GENOME EDITING MARKET REVENUE FORECASTS AND ANALYSIS

5.2 MARKET POSITIONING

5.3 PERFORMANCE OF KEY PLAYERS

5.4 EXPERT OPINIONS

PART 6. NORTH AMERICA GENOME EDITING MARKET ANALYSIS - BY TECHNOLOGY

6.1 OVERVIEW

6.2 NORTH AMERICA GENOME EDITING MARKET, BY TECHNOLOGY, 2017 & 2025 (%)

6.3 NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

6.4 TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) MARKET

6.4.1 Overview

6.4.2 North America Transcription Activator-Like Effector Nucleases (TALENS) Market Revenue and Forecasts to 2025 (US$ Mn)

6.5 CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET

6.5.1 Overview

6.5.2 North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2025 (US$ Mn)

6.6 ZINC FINGER NUCLEASES (ZFNS) MARKET

6.6.1 Overview

6.6.2 North America Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2025 (US$ Mn)

6.7 ANTISENSE RNA MARKET

6.7.1 Overview

6.7.2 North America Antisense RNA Market Revenue and Forecasts to 2025 (US$ Mn)

6.8 OTHERS MARKET

6.8.1 Overview

6.8.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. NORTH AMERICA GENOME EDITING MARKET ANALYSIS - BY APPLICATION

7.1 OVERVIEW

7.2 NORTH AMERICA GENOME EDITING MARKET, BY APPLICATION, 2017 & 2025 (%)

7.3 NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

7.4 GENETIC ENGINEERING MARKET

7.4.1 Overview

7.4.2 North America Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.4.3 Animal Genetic Engineering Market

7.4.3.1 Overview

7.4.3.2 North America Animal Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.4.4 Plant Genetic Engineering Market

7.4.4.1 Overview

7.4.4.2 North America Plant Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.5 CELL LINE ENGINEERING MARKET

7.5.1 Overview

7.5.2 North America Cell Line Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.6 OTHERS MARKET

7.6.1 Overview

7.6.2 North America Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. NORTH AMERICA GENOME EDITING MARKET ANALYSIS - BY END USER

8.1 OVERVIEW

8.2 NORTH AMERICA GENOME EDITING MARKET, BY END USER, 2017 & 2025 (%)

8.3 NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

8.4 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET

8.4.1 Overview

8.4.2 North America Biotechnology & Pharmaceutical Companies Market Revenue and Forecasts to 2025 (US$ Mn)

8.5 ACADEMIC & GOVERNMENT RESEARCH ORGANIZATIONS MARKET

8.5.1 Overview

8.5.2 North America Drug Manufacturers Market Revenue and Forecasts to 2025 (US$ Mn)

8.6 CONTRACT RESEARCH ORGANIZATION MARKET

8.6.1 Overview

8.6.2 North America Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025

9.1 OVERVIEW

9.2 NORTH AMERICA GENOME EDITING TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.3 NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

9.4 NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

9.4.1 North America Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.5 NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

9.6 NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

9.7 US GENOME EDITING TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.7.1 US Genome Editing testing market Revenue and Forecasts to 2025 (US$ Mn)

9.8 US GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.8.1 US Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)

9.8.2 US Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

9.8.3 US Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.8.3.1 US Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.8.4 US Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)

9.9 CANADA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.9.1 Canada Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)

9.9.2 Canada Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

9.9.3 Canada Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.9.3.1 Canada Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.9.4 Canada Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)

9.10 MEXICO GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.10.1 Mexico Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)

9.10.2 Mexico Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

9.10.3 Mexico Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.10.3.1 Mexico Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.10.4 Mexico Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)

PART 10. GENOME EDITING MARKET-KEY COMPANY PROFILES

10.1 THERMO FISHER SCIENTIFIC INC.

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Financial Overview

10.1.4 Product Portfolio

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 INTEGRATED DNA TECHNOLOGIES, INC.

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Financial Overview

10.2.4 Product Portfolio

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 MERCK KGAA

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Financial Overview

10.3.4 Product Portfolio

10.3.5 SWOT ANALYSIS

10.3.6 KEY DEVELOPMENTS

10.4 LONZA

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Financial Overview

10.4.4 Product Portfolio

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 NEW ENGLAND BIOLABS

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Financial Overview

10.5.4 Product Portfolio

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 GENSCRIPT

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Financial Overview

10.6.4 Product Portfolio

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 TRANSPOSAGEN BIOPHARMACEUTICALS, INC.

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Financial Overview

10.7.4 Product/ Services Portfolio

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 HORIZON DISCOVERY GROUP PLC

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Financial Overview

10.8.4 Product/ Services Portfolio

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 SANGAMO THERAPEUTICS, INC.

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Financial Overview

10.9.4 Product Portfolio

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 EDITAS MEDICINE

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Overview

10.10.4 Service Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

PART 11. APPENDIX

11.1 ABOUT THE INSIGHT PARTNERS

11.2 GLOSSARY OF TERMS

11.3 METHODOLOGY

11.3.1 Coverage

11.3.2 Secondary Research

11.3.3 Primary Research

LIST OF TABLES

TABLE 1. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 2. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 3. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 4. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 5. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 6. NORTH AMERICA GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 7. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 8. US GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 9. US GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 10. US GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 11. US GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 12. CANADA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 13. CANADA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 14. CANADA GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 15. CANADA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 16. MEXICO GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 17. MEXICO GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 18. MEXICO GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 19. MEXICO GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 20. GLOSSARY OF TERMS, GENOME EDITING MARKET

LIST OF FIGURES

FIGURE 1. US GENOME EDITING MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2025

FIGURE 2. NORTH AMERICA GENOME EDITING MARKET BY TYPE, MARKET SHARE (%), 2017

FIGURE 3. NORTH AMERICA GENOME EDITING MARKET BY SERVICES, MARKET SHARE (%), 2017

FIGURE 4. NORTH AMERICA GENOME EDITING MARKET BY END USER, MARKET SHARE (%), 2017

FIGURE 5. GENOME EDITING MARKET SEGMENTATION

FIGURE 6. NORTH AMERICA PEST ANALYSIS

FIGURE 7. GENOME EDITING MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 8. NORTH AMERICA GENOME EDITING MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025

FIGURE 9. NORTH AMERICA GENOME EDITING MARKET, BY TECHNOLOGY, 2017 & 2025 (%)

FIGURE 10. NORTH AMERICA TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 11. NORTH AMERICA CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 12. NORTH AMERICA ZINC FINGER NUCLEASES (ZFNS) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 13. NORTH AMERICA ANTISENSE RNA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 14. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 15. NORTH AMERICA GENOME EDITING MARKET BY APPLICATION, 2017 & 2025 (%)

FIGURE 16. NORTH AMERICA GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 17. NORTH AMERICA ANIMAL GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 18. NORTH AMERICA PLANT GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 19. NORTH AMERICA CELL LINE ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 20. NORTH AMERICA OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 21. NORTH AMERICA GENOME EDITING MARKET BY END USER, 2017 & 2025 (%)

FIGURE 22. NORTH AMERICA BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET REVENUE AND FORECASTS TO 2025

(US$ MN)

FIGURE 23. NORTH AMERICA DRUG MANUFACTURERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 24. NORTH AMERICA RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 25. NORTH AMERICA GENOME EDITING MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)

FIGURE 26. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 27. NORTH AMERICA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

FIGURE 28. US GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 29. US GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 30. CANADA GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 31. MEXICO GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370